Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory lower-risk MDS Dr. Myint, a hematology leader and oncology drug-development executive, joins Halia to lead clinical development as ofirnoflast (HT-6184) advances toward pivotal trials LEHI, Utah, May 12, 2026 /PRNewswire/...
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development
SHANGHAI, May 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has entered a strategic collaboration agreement with Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK), a globally leading clinical-stage company in oligonucleotide therapeutics. Building upon the automation, intelligence and scalability capabilities of Insilico's LifeStar 2 laboratory,...
Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
SUZHOU, China, May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine ("Insilico", 03696.HK). Both parties will leverage their respective core strengths in siRNA drug development and AI-powered drug discovery to conduct in-depth collaboration in...
Avance Clinical Receives Frost & Sullivan’s 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership
The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements...
New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
Longitudinal analysis reveals clear gaps in global preparedness against emerging viral threats and future pandemics. CAMBRIDGE, Mass., May 12, 2026 /PRNewswire/ -- New global analysis of antiviral compounds released today has identified a critically thin pipeline of treatments in development that target some of the 14 viral families with the greatest pandemic...
HKSH Medical Group Named Asia’s first Photon-Counting CT Simulator Reference Site, Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers
HONG KONG, May 12, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and global medical technology leader Siemens Healthineers today signed a collaboration agreement at the "Asia Summit on Global Health", establishing HKSH as Siemens Healthineers' first Photon‑Counting Computed Tomography Simulator (PCCT‑Sim) Reference Site in Asia. For driving the development of PCCT-Sim technology, HKSH is not only Siemens Healthineers' research...
The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec
SHANGHAI, May 12, 2026 /PRNewswire/ -- In 2026, the surgical robotics industry continues to grow steadily. Recent reports show that both procedure volumes and system deployments are rising consistently. Intuitive Surgical surpassed expectations in its Q1 earnings, installing 431 da Vinci systems globally and generating $2.77 billion in revenue, a 23% increase year-on-year,. This reflects a broader trend: the...
BGI Genomics joins HGP2 Rare Disease Alliance to Close Rare Disease Care Gap in Asia-Pacific
KUALA LUMPUR, Malaysia, May 12, 2026 /PRNewswire/ -- The HGP2 Rare Disease Alliance of the Asia-Pacific Region (HGP2 RaDiAnce–APAC) was officially launched in Kuala Lumpur on May 10. YBhg. Datuk Dr. Nor Fariza Binti Ngah, Deputy Director-General of Health (Research and Technical Support) at the Ministry of Health of Malaysia, and Hou Yong, General Manager of BGI Genomics, joined leading...
TEDxSugar Hill 2026 Announces Yosi Amram: Beyond IQ and EQ — The Rise of Spiritual Intelligence
SUGAR HILL, Ga., May 12, 2026 /PRNewswire/ -- Nearly three decades ago, national headlines told a dramatic story: "Individual Inc.'s CEO, Amram, Takes Leave, and Stock Drops." — Wall Street Journal"Founder of Individual takes leave and shares fall 37%." — The New York Times"Yosi Amram, the founder of Individual Inc., was fired as chief executive by his board." —...
DNA ‘barcodes’ help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies SINGAPORE, May 12, 2026 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to mitochondria (the energy centres...
